Abstract: A palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain and also for use as aphrodisiac, comprising the dried extract of the roots of Chlorophytum spp in an amount of 500 mg to 1.0gm; the dried extracts of the roots of Withania spp in an amount of 200mg to 1.0gm along with one or more suitable herbal additives.
COMPLETE AFTER PROVISIONAL LEFT ON
FORM 2
THE PATENT ACT 1970
(39 of 1970) & The Patents Rules, 2003
COMPLETE SPECIFICATION
(See section 10 and rule l3)
1. TITLE OF THE INVENTION:
"Medicinal Composition"
2. APPLICANT
(a) NAME : L'AMAR NATURAL PRODUCTS PRIVATE LIMITED
(b)NATIONALITY : Indian Company incorporated under the Indian
Companies ACT, 1956
(c) ADDRESS : 12, Gunbow Street, Fort, Mumbai - 400 001,
Maharashtra, India
3.PREAMBLE TO THE DESCRIPTION
The following specification particularly describes the invention and the manner
in which it is to be performed.
Technical field:
The present invention relates to a palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain and also for use as aphrodisiac, as a general health tonic. It further also relates to the process of preparing the same.
Background and prior art:
Men who are in their midlife are standing on the threshold of a 'new youth'. It is also called as 'second adulthood'. What possibly comes in the way of enjoying the 'second adulthood' is the impact of modern lifestyle on the energy levels, stamina as well as drive. The causes and effects of modern lifestyles include stress factors and environmental pollution. Stress produces excess levels of hormone Cortisol in our bodies and can have a negative effect on memory and concentration. Since the beginning of man's recorded history, herbs have been used to enhance mood, pleasure and sexual response. There is an increasing scientific evidence to support historical lore regarding the use of herbs as energy boosters as well as aphrodisiacs.
US2002068728 describes a natural composition for boosting the libido of an individual, the composition including an effective amount of an aphrodisiac and a compound to increase blood flow to the pelvic area in a pharmaceutically acceptable carrier.
US5059603 describes the topical administration of isoxsuprine and caffeine, and nitroglycerine and caffeine along with suitable carrier compounds for the treatment of impotence.
Sonda et al. J. Sex & Marital Ther. 16(1): 15-21 (year) reported that yohimbine ingestion resulted in subjective improvement in erectile ability in 38% of impotent men treated, but only 5% of the treated patients reported complete satisfaction.
Zorgniotti et al, PCT/US94/09048, describes the transmucosal administration of a variety of vasodilators including phentolamine mesylate for modulating the human sexual
2
response.
Viagra.RTM. available from Pfizer contains sildenafil citrate for oral administration that also acts as an aphrodisiac but many persons are not candidates for this as a result of their physiological condition since oral administration of sildenafil citrate is contraindicated for individuals currently taking organic nitrates, such a nitroglycerine.
There are many herbs available in nature that are used as aphrodisiac. But of these few herbs like Kawach beej (Mucuna pruriens), Safed Musli (Chlorophytum arundinaceum), Vidarikand (Pueraria turberosa), Ashwagandha (Withania somnifera), Shatavari (Asparagas racemosus) etc have been used to a larger extent as aphrodisiacs. This is the reason most of the herbal combinations contain these herbs.
RO117897 relates to a revitalizing Ayurveda supplement for males, prepared of oriental plants and East- and West-European flora, employed to prophylactic purposes in the treatment of several metabolic malfunctions and/or for stimulating some physiological functions of the organism, playing a nutritive part with respect thereto. The claimed supplement comprises 80 g of Asparagus racemosus (sin A javanicus); 90 g Asphaltum (shilajit); 60 g of Boerhavia diffuza; 70 g of Centipeda minima; 10 g of Cinnamomi cortex (cinnamon); 30 g of Chlorophytum arundinaceum; 20 g of Corallium rubrum (Coral Bhasm); 10 g of Elletaria cardamomum; 100 g of Gummi accacia; 10 g of Mesua ferrea; 80 g of Mucuna prurita; 10 g of Myristica fragrans; 40 g of Spheranthus indicus; 120 g of Sida cordifolia; 70 g of Strichnos potatorum; 80 g of Tribulus terrestris; 10 g of Piper longum; 20 g of Zinci carbonas and 20 g of Zingiber officinale. All these components, as powder, are mixed, homogenized and processed as uncoated tablets of 500 mg.
A formulation marketed by Baidyanath also contains Ashwagandha (Withania somnifera), Shilajit, Araka bhasma, safed musli (Chlorophytum arundinaceum) with other ingredients and is available as a capsule to be taken with milk or water for richer, fuller and energetic life.
3
Another formulation marketed by Charak contains Ashwagandha (Withania somnifera) and Safed Musli (Chlorophytum arundinaceum) as a health drink.
There are also several documented herbal remedies in the literature that refer to the use of the herbs exhibiting aphrodisiac activity with milk.
But the problem with the formulations in the prior art is that since many of the active ingredients are chemically synthesized they might have side effect. Also those that are from the natural source are highly unpalatable. Most of these drugs are extremely bitter and masking the taste to make it palatable is a challenging task. Another drawback seen with the prior art formulation is that they need to be taken with a vehicle like water or milk. Instead one would definitely prefer a formulation that does not require to be taken with any vehicle but is yet palatable.
The present invention provides a solution to all these and presents a formulation containing natural ingredients but is yet palatable.
Objectives of the Invention:
The object of the present invention is to provide a medicinal composition that is palatable.
It is another object of the present invention to provide a palatable medicinal composition comprising a therapeutically effective amount of Chlorophytum species (spp) and Withania species (spp) with one or more suitable herbal additives.
It is yet another object of the present invention to provide a palatable medicinal composition according to the present invention for use as an aphrodisiac, as a general health tonic.
It is another object of the present invention to provide a palatable medicinal composition according to the present invention that increases vigor and vitality, reduces fatigue, stress
4
and strain.
It is yet another object of the present invention to provide a process to manufacture a palatable medicinal composition according to the present invention.
Summary of the invention:
According to the present invention there is provided a palatable medicinal composition comprising a therapeutically effective amount of Chlorophytum spp and Withania spp with one or more suitable herbal additives.
According to another aspect of the present invention there is provided a process to manufacture a palatable medicinal composition according to the present invention.
According to yet another aspect of the present invention there is provided a palatable medicinal composition for use as an aphrodisiac, as a general health tonic.
According to yet another aspect of the present invention there is provided a palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain.
Detailed description of the invention:
The aphrodisiacs are substances that excite sexual desire in a person. There are several drugs that are commercially available for use as aphrodisiacs but since they are chemically synthesized they may have side effects.
Thus the present invention relates to a formulation containing natural ingredients and is also palatable.
There are several natural drugs reported in literature having aphrodisiac activity like Kawach beej (Mucuna pruriens), Safed Musli (Chlorophytum arundinaceum), Vidarikand (Pueraria turberosa), Ashwagandha (Withania somnifera), Shatavari
5
(Asparagas racemosus),Yohimbine, Jatamansi (Nardostachys jatamansi), Gokhru (Tribulus terrestris), but the preferred ones according to the present invention are Chlorophytum arundinaceum and Withania somnifera.
The term "species" (spp) described in the specification and claims refers to various species falling under the specified genus.
A major drawback with all these natural drugs is that they have a bitter taste and masking this taste is a challenging task.
The present invention provides a palatable medicinal composition comprising therapeutically effective amount of Chlorophytum spp and Withania spp with other suitable herbal additives.
Chlorophytum spp.
According to the present invention, the species used is Chlorophytum species belonging to the family liliaceae. The different species include for eg. Chlorophytum arundinaceum, Chlorophytum borivilianum, Chlorophytum tuberosum, Chlorophytum laxum. The preferred species according to the present invention are Chlorophytum arundinaceum, Chlorophytum borivilianum. It is also known as Safed Musli, and is a potent herb whose root; tubers have been in use for aphrodisiac and health promotion purposes since 11th century A.D. It is rich source of over 25 alkaloids, vitamins, minerals, proteins, carbohydrates, steroid, saponins and polysaccharides etc. It contains saponins like sigmasterol and hecogenin that are herbal steroids. Roots are used for the preparation of nutritive tonic used in general sexual weakness. It has got wide usage in Ayurveda, Unani and Allopathy. It is very useful as a curative for physical weakness and many illnesses, as a curative for natal and post-natal problems, as an aphrodisiac agent and vitalizer, as a general sex tonic, as an immunity-improving drug, as a remedy for diabetes, as a remedy for arthritis. The therapeutically effective range of Chlorophytum spp is about 500mg to 1 .Ogm. Hence the formulation may contain varying amount of Chlorophytum spp such that the patient takes the formulation in such a therapeutic regime that he receives a desired therapeutic dose. Preferably a dried extract of the roots of Chlorophytum spp is
6
used.
Withania spp
The species used according to the present invention is Withania species and belongs to the family solanaceae. The different species available are for eg. Withania ashwagandha, Withania somnifera. The preferred species according to the present invention is Withania somnifera. It is also known as ashwagandha and has tonic, alterative, astringent, aphrodisiac action. The roots also have diuretic and deobstruent, tonic, alterative and aphrodisiac activity. It is also useful in cases of general debility, nervous exhaustion, loss of muscular energy and spermatorrhoea. The main constituents of ashwagandha are alkaloids and steroidal lactones. Among the alkaloids, withanine is an important constituent. Besides the alkaloids the roots also contain a group of steroidal lactones called withanolides. It is said to work mainly on the reproductive and nervous systems coupled with rejuvenating qualities. It is commonly used to increase vitality, recover from chronic illnesses and pain management for arthritic conditions. The therapeutically effective range of Withana spp is about 200mg to l.0gm. Hence the formulation may contain varying amount of Withania spp such that the patient takes the formulation in such a therapeutic regime that he receives a desired therapeutic dose. Preferably a dried extract of the roots of Withania spp is used.
Since these drugs are extremely bitter, the bitter taste needs to be masked adequately to make it palatable. Several experiments were carried out to develop a palatable formulation. Firstly the two drugs were used as powder form of the crude drugs with other herbs like amlaki (Emblica officinalis), kala draksha (Vitis vinifera), khajura (Phoenix dactylifera), china (Elusine coracana), and other ingredients like flavors, to be administered with milk but the problem was that the bitter taste was not sufficiently masked and the bitter taste persisted after consuming the product. Another problem was that of inadequate dosing of the drug. Some of the ingredients in the above product remained insoluble in milk, and so they remained settled at the bottom of the container. As a result there were chances of inadequate dose administration.
It was observed that the ingredient china (Elusine coracana) was not soluble in the milk
7
and hence led to the product being less soluble in milk.
Thus in the further experiment, the quantity of china (Elusine coracana) was reduced. Also it was decided to use the dried extract of the roots of Safed Musli (belonging to the Chlorophytum spp) and Ashwagandha (belonging to the Withania spp), since it was felt that using the extract might help to reduce the bitter taste. But it was observed that although the taste of the formulation had improved, the bitter taste was not sufficiently masked. It was also observed that some formulation still remained settled at the bottom of the container.
Hence, it was decided to use the dried extract of the roots of Safed Musli (belonging to the Chlorophytum spp) and Ashwagandha (belonging to the Withania spp), but bring in a complete change in the other ingredients of the formulation.
Surprisingly, it was found that when jeeraka or cummin (belonging to the Cuminum spp), ajowan (belonging to the Trachyspermum spp), fennel (belonging to the Foeniculum spp), Tamarind or imli (belonging to the Tamarindus spp), Saindhav namak (rock salt) were used with the dried extracts of the roots of Chlorophytum spp and Withania spp, it helped to mask the bitter taste of the drug. Further on the addition of sweetners there was sufficient masking of the bitter taste, but it was observed that it left a bitter after taste.
Hence, it was decided to increase the percentage of tamarind (belonging to the Tamarindus spp) to 30% from 20% and also added lime juice (belonging to the fruit of citrus spp) to the formulation. It was observed that this helped to reduce the bitter after taste but it did not help to eliminate it completely.
It was then decided to include another ingredient, kali miri or pepper (belonging to the Piper spp) to the formulation and also vary the percentages of the other ingredients. Surprisingly it was found that the bitter after taste was eliminated completely.
8
The above mentioned experiments are tabulated below.
Sr.no. Ingredients Qty % (I) Qty % (ii) Qty % (III)
1. Cummin 3.00 3.00 4.00
2. Ajowan 2.00 2.00 1.00
3. Fennel 2.00 2.00 1.00
4. tamarind 20.00 30.00 30.00
5. Saindhav namak (rock salt 2.00 2.00 2.00
6. lime juice - 1.00 2.00
7. pepper - - 0.50
8. Sugar qs qs qs
Result Bitter after taste Slightly Bitter after taste, but better than I Complete masking of the slight bitter after taste
Thus according to the present invention the preferred formula to be used with dried extracts of the roots of Chlorophytum spp and Withania spp is formula III
Another advantage of formulation according to the present invention is that it rapidly melts in the mouth upon administration. Yet another advantage is that it obviates the need for any vehicle like milk or water to administer the formulation and is also useful for the patient who are unwilling to take oral solid dosage forms. Also it contains ingredients that are good digestives and carminatives and hence the formulation can serve as a good mouth freshner and such a formulation will definitely be preferred over a capsule or other bitter formulations.
In the present invention, the dried extracts of the roots of Safed musli and Ashwagandha is used. The extracts can be of different types and can be made by different processes. The extracts used according to the present invention are preferably water extracts. The water extracts may be obtained by different methods. The dried extract of the roots of
9
Safed Musli (belonging to the Chlorophytum spp) can be obtained by extracting the powdered root of Safed Musli with water. The water extract is then dried for few days and the dried extract is then collected. The dried extract of the roots of Ashwagandha (belonging to the Withania spp) can be prepared by extracting the powdered roots of Ashwagandha with water and then drying the aqueous extract to get a fine powder.
Hence in another embodiment of the present invention there is provided a palatable medicinal composition comprising one or more of suitable herbal additives selected from but not limited to Cuminum spp, Trachyspermum spp, Foeniculum spp, Piper spp, Citrus spp, Tamarindus spp, Saindhav namak (rock salt) along with the dried extract of the roots of Chlorophytum spp and Withania spp and other suitable additives.
Cuminum spp
The species used according to the present invention is Cuminum species and belongs to the family umbellifereae. The preferred species according to the present invention is Cuminum cyminum. It is also known as Jeeraka or cumin and mainly consists of the dried ripe fruits. It is a carminative, stomachic, stimulant, astringent. Its main constituents include fatty oil, resin, mucilage, gum, protein compounds and essential oil. The essential oil, thymene is rich in carvone, contains cuminol or cuminic aldehyde and is responsible for the aromatic odour and taste of jeeraka. The formulation may contain varying amount of Cuminum spp as per requirement; preferably the Cuminum spp can be used in the range of about 0.375gm to 1.50gm. Instead of Cuminum cyminum, another variety of jeeraka known as Carum carvi can also be used.
Trachyspermum spp.
The species used according to the present invention is Trachyspermum species and belongs to the family umbellifereae. The preferred species according to the present invention is Trachyspermum ammi (also known as Carum copticum). It is also known as ajowan and mainly consists of dried ripe fruits. It is a carminative, stimulant, stomachic, tonic, antispasmodic and digestive. The essential component of ajowan includes an aromatic volatile essential oil and a crystalline substance stearopin, known as crude thymol. It also contains other constituents like cumene and a terpene, thymene. The
10
formulation may contain varying amount of trachyspermum spp as per requirement; preferably the Trachyspermum spp can be used in a range of 0.1 gm to 4.50gm.
Foeniculum spp
The species used according to the present invention is Foeniculum species and belongs to the family umbellifereae. The preferred species according to the present invention is Foeniculum vulgare. Also known as madhurica or fennel it mainly consists of dried ripe fruits. It is a carminative, stimulant, stomachic, tonic, astringent. The constituents of fennel include volatile oil, proteins and fixed oil. The chief constituent of volatile oil is a ketone, fechnone and a phenolic ether anethole. The other constituents include phellandrene, limonene, methyl chavicol, anisic aldehyde etc. The formulation may contain varying amount of foeniculum spp as per requirement, preferably the Foeniculum spp can be used in a range of 0.1 gm to 1.50gm.
Piper spp
The species used according to the present invention is Piper species and belongs to the family piperaceae. The different species available are for eg. Piper nigrum, Piper longum, Piper cubeba. The preferred species according to the present invention is Piper nigrum. It mainly consists of the dried unripe fruit. It is also known as pepper or kali miri, it is a carminative, mild aphrodisiac, diuretic, stimulant. It stimulates the local circulation. The constituents contain alkaloid piperine, volatile oil and pungent resin, piperidine and starch. The volatile oil contains mainly 1-phellandrene and caryophyllene. The formulation may contain varying amount of Piper spp as per requirement; preferably the Piper spp can be used in a range of 0.02gm to 0.50gm.
Citrus spp
The species used according to the present invention is Citrus species and it belongs to the family rutaceae. The different species available are for eg Citrus limon, citrus medica, Citrus medica, var.acida. The preferred species according to the present invention is Citrus medica var.acida, Citrus medica and Citrus limon. Preferably the juice of the ripe
11
fruit may be used. It is also known as lemon or nimbaka and is used as a stomachic and carminative. The constituents include citrene or limonene, citrol, and citronellal. The Citrus spp can be used in varying amount as per requirement, but can preferably be used in the range of about 0.1 gm to 0.5gm
Tamarindus spp
The species used according to the present invention is Tamarindus species and it belongs to the family leguminosae. The preferred species according to the present invention is Tamarindus indica. Preferably the pulp of the fruit may be used. It is also known as Tamarind and is a carminative, Refrigerant, Digestive. The constituents include tartaric acid, citric acid, malic and acetic acids, tartaric of potassium. The Tamarindus spp can be used in a range as per requirement, but can preferably be used in the range of about lgm to 5gm.
Saindhav namak
Saindhav namak (Rock salt) is obtained from the mines and is available as big block of the salt. It is a stomachic, digestive and aids to enhance the taste of the formulation. The Rock salt can be used in a range as per requirement, but can preferably be used in the range of 0.lgm to 0.4gm. Since rock salt has medicinal properties it is preferred according to the present invention, else table salt i.e sodium chloride can also be used.
The ranges of Tamarind spp, citrus spp, Saindhav namak can vary as per requirement.
Thus in one embodiment of the present invention there is provided a palatable medicinal composition comprising one or more suitable herbal additives selected from but not limited to Cuminum spp in a range of 0.375gm to 1.50gm, Trachyspermum spp in a range of 0.lgm to 4.5gm, Foeniculum spp in a range of 0.lgm to 1.50gm, Piper spp in a range of 0.02gm to 0.5 gm, Citrus spp in a range of 0.lgm to 0.5gm, Tamarindus spp in a range of 1 gm to 5gm, Saindhav namak (rock salt) in a range of 0.lgm to 0.4gm with other suitable additives.
12
Other ingredients
In addition to these, the composition also consists of sweeteners to increase the palatability. The sweeteners may be used from variety of pharmaceutically acceptable sweeteners, including, but not limited to sugar.
The formulation also contains preservatives to ensure microbial stability throughout the shelf life. The preservatives may be used from variety of pharmaceutically acceptable preservatives, including, but not limited to methyl and propyl parabens or their salts or derivatives thereof, sodium benzoate, potassium sorbate etc. The more preferable preservatives according to the present invention are sodium methyl paraben and sodium propyl paraben.
In one embodiment of the present invention, the formulation is preferably in the form of granules. More preferably the granules according to the present invention are provided in a sachet.
In another embodiment of the present invention the granules may further be compressed to form tablets or formulated as pill using suitable additives.
Thus in one embodiment of the present invention there is provided a palatable medicinal composition in the form of granules comprising Chlorophytum spp 0.60gm, Withania spp 0.20gm, Cuminum spp 0.40gm, Trachyspermum spp 0.1 Ogm, Foeniculum spp 0.1 Ogm, Piper spp 0.05gm, Citrus spp 0.20gm, Tamarindus spp 3.00gm, Saindhav namak (rock salt) 0.20gm, Sodium methyl paraben 0.02gm, Sodium Propyl paraben 0.002gm, Sugar q.s
In another embodiment of the present invention there is provided a palatable medicinal composition in the form of granules comprising Chlorophytum arundinaceum 0.60gm, Withania somnifera 0.20gm, Cuminum cyminum 0.40gm, Trachyspermim ammi 0.1 Ogm, Foeniculum vulgare 0.1 Ogm, Piper nigrum 0.05gm, Citrus medica 0.20gm, Tamarindus indica 3.00gm, Saindhav namak (rock salt) 0.20gm, Sodium methyl paraben 0.02gm, Sodium Propyl paraben 0.002gm, Sugar q.s.
13
In one embodiment of the present invention there is provided a process to manufacture the composition according to the present invention, which process comprises making a pulp of Tamarindus indica, adding the juice of Citrus medica, preservatives and Saindhav namak (rock salt), followed by the addition of the Chlorophytum arundinaceum, Withania somnifera and sweetner.
The process further comprises the addition of Cuminum cyminum, Piper nigrum followed by the addition of Trachyspermum ammi, Foeniculum vulgare and drying the mass so formed at a temperature not greater than 60°C.
Different sizes of meshes may be used at various stages of the manufacture of the formulation to obtain a composition that melts in the mouth.
In another embodiment of the present invention there is provided a process to manufacture the formulation according to the present invention, which process comprises making a pulp of Tamarindus indica by soaking in water preferably in a ratio of 1:1 .This is then passed through #20. To the pulp so obtained is added the lime juice, Saindhav namak, preservatives, dried extracts of the roots of Withania somnifera, and Chlorophytum arundinaceum, powdered sugar (all sifted through #60). This is then blended in a mass mixer. To this is added the powders of Cuminum cyminum, Piper nigrum followed by the addition of powders of Trachyspermum ammi, Foeniculum vulgare (all powders passed through #40). The mass so obtained is then dried at a temperature not greater than 60°C. The semidried mass is again passed through #8, and further dried. Finally it is passed through #30 and the weight is made up using powdered and sifted sugar.
In a further embodiment the dried mass so obtained may be compressed to form tablets or may be formulated as pills using suitable additives.
The process according to the present invention yields a composition that rapidly melts in the mouth.
14
The palatable medicinal composition according to the present invention boosts performance, improves mood and revitalises the body and mind. It is good for men to increase vigor and vitality, to reduce fatigue, stress and strain, as an aphrodisiac, as a general health tonic.
Since it contains other ingredients that are natural digestives the present invention can also act as a good after food digestive as well.
Thus in one embodiment of the present invention there is provided a palatable medicinal composition for use as an aphrodisiac, as a general health tonic comprising Withania spp in the range of about 200mg tol.Ogm., Chlorophytum spp in the range of about 500mg tol.Ogm., Cuminum spp in a range of 0.375gm to 1.50gm, Trachyspermum spp in a range of 0.lgm to 4.5gm, Foeniculum spp in a range of 0.lgm to 1.50gm , Piper spp in a range of 0.02gm to 0.5 gm, Citrus spp in a range of 0.lgm to 0.5gm, Tamarindus spp in a range of 1 gm to 5gm, saindhav namak (rock salt) in a range of 0.lgm to 0.4gm with suitable additives.
According to the present invention there is also provided a palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain comprising Withania spp in the range of about 200mg tol.Ogm., Chlorophytum spp in the range of about 500mg tol.Ogm., Cuminum spp in a range of 0.375gm to 1.50gm, Trachyspermum spp in a range of 0.lgm to 4.5gm, Foeniculum spp in a range of 0.lgm to 1.50gm, Piper spp in a range of 0.02gm to 0.5 gm, Citrus spp in a range of 0.lgm to 0.5gm, Tamarindus spp in a range of 1 gm to 5gm, saindhav namak (rock salt) in a range of 0.lgm to 0.4gm with suitable additives.
It will be readily apparent to one skilled in the art that varying substitutions and modifications may be made to the invention disclosed herein without departing from the scope and spirit of the invention. Thus, it should be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to
15
by those skilled in the art, and that such modifications and variations are considered to be falling within the scope of the invention.
The following examples are for the purpose of illustration of the invention only and are not intended in any way to limit the scope of the invention.
Example:
Sr. No. INGREDIENTS QTY(gm)./per sachet of 10 gm
1. Safed musli (Chlorophytum arundinaceum) 0.60
2. Ashwagandha (Withania somnifera) 0.20
3. Jeeraka (Cuminum cyminum) 0.40
4. Ajowan {Trachyspermum ammi) 0.10
5. fennel (Foeniculum vulgare) 0.10
6. pepper (Piper nigrum) 0.05
7 Saindhav namak (Rock salt) 0.20
8. Nimbaka (Citrus medica) 0.20
9. Tamarind (Tamarindus indica) 3.00
10. Sodium methyl paraben 0.02
11. Sodium propyl paraben 0.002
12. Sugar q.s
A pulp of Tamarindus indica was made and (the juice of) Citrus medica, sodium methyl paraben, sodium propyl paraben and Saindhav namak (rock salt) was added to it. This was followed by the addition of the Chlorophytum arundinaceum, Withania somnifera and sugar. To this Cuminum cyminum, Piper nigrum, Trachyspermum ammi, Foeniculum vulgare was added and the resulting mass was dried at a temperature not greater than 50°C. The semi dried mass was then sifted through 8 mesh and further dried. Finally the granules were passed through 30 mesh and the weight was made up with sugar.
16
Stability studies:
The medicinal compositions of the present invention are found to be stable under normal storage conditions. Also no color change has been observed during the storage period. The stability data is presented in a chart below.
We claim,
1. A palatable medicinal composition comprising a therapeutically effective amount Chlorophytum spp and Withania spp along with one or more suitable herbal additives.
2. A palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain comprising a therapeutically effective amount Chlorophytum spp and Withania spp along with one or more suitable herbal additives for use as an aphrodisiac, as a general health tonic.
3. The palatable medicinal composition as claimed in any of the claims 1 or 2, wherein Chlorophytum spp comprises the dried extract of the roots of Chlorophytum spp.
4. The palatable medicinal composition as claimed in any of the claims 1 or 2, wherein Withania spp comprises the dried extracts of the roots of Withania spp.
5. The palatable medicinal composition as claimed in any of the claims 3 or 4, wherein said extracts are water extracts.
6. The palatable medicinal composition as claimed in any of the preceding claims, wherein Chlorophytum spp is present in a therapeutically effective range of 500 mg to 1 gm.
7. The palatable medicinal composition as claimed in any of the preceding claims, wherein Withania spp is present in a therapeutically effective range of 200 mg to lgm.
8. The palatable medicinal composition as claimed in any of the claims 1 to 7, wherein said Chlorophytum spp is selected from Chlorophytum arundinaceum, Chlorophytum laxum, Chlorophytum borivilianum and Chlorophytum tuberosum.
9. The palatable medicinal composition as claimed in claim 8, wherein said Chlorophytum spp is Chlorophytum arundinaceum or Chlorophytum borivilianum.
10. The palatable medicinal composition as claimed in any of the preceding claims, wherein said Withania spp is selected from Withania ashwagandha and Withania somnifera.
11. The palatable medicinal composition as claimed in claim 10, wherein said
18
Withania spp is Withania somnifera.
12. The palatable medicinal composition as claimed in any of the preceding claims,
wherein said suitable herbal additives comprise one or more of Cuminum spp,
Trachyspermum spp, Foeniculum spp, Piper spp, Citrus spp, and Tamarindus
spp., Saindhav namak.
13. The palatable medicinal composition as claimed in any of the preceding claims wherein the Cuminum spp is Cuminum cyminum.
14. The palatable medicinal composition as claimed in any of the claims 12 or 13, wherein the Cuminum spp is in the range of 0.375gm to 1.50gm.
15. The palatable medicinal composition as claimed in any of the preceding claims wherein the Trachyspermum species is Trachyspermum ammi.
16. The palatable medicinal composition as claimed in any of the claims 12 or 15, wherein the, wherein the Trachyspermum spp is in the range of from 0.1 gm to 4.50gm.
17. The palatable medicinal composition as claimed in any of the preceding claims wherein the Foeniculum spp is Foeniculum vulgare.
18. The palatable medicinal composition as claimed in any of the claims 12 or 17, wherein the Foeniculum spp is in the range of 0.1 gm to 1.50gm.
19. The palatable medicinal composition as claimed in any of the preceding claims wherein the Piper spp is Piper nigrum.
20. The palatable medicinal composition as claimed in any of the claims 12 or 19, wherein the Piper spp is in the range of 0.02gm to 0.5gm.
21. The palatable medicinal composition as claimed in any of the preceding claims wherein the Citrus spp is Citrus medica var. acida, Citrus medica, Citrus limon.
22. The palatable medicinal composition as claimed in any of the claims 12 or 21, wherein the citrus spp is in the range of from 0.1 gm to 0.5gm.
23. The palatable medicinal composition as claimed in any of the preceding claims wherein the Tamarindus spp is Tamarindus indica.
24. The palatable medicinal composition as claimed in any of the claims 12 or 23, wherein the tamarindus spp is in the range of 1 gm to 5gm.
25. The palatable medicinal composition as claimed any of the preceding claims, wherein the Saindhav namak is in the range of 0.1 gm to 0.4gm.
19
ABSTRACT:
A palatable medicinal composition that increases vigor and vitality, reduces fatigue, stress and strain and also for use as aphrodisiac, comprising the dried extract of the roots of Chlorophytum spp in an amount of 500mg to l.0gm; the dried extracts of the roots of Withania spp in an amount of 200mg to 1.0gm along with one or more suitable herbal additives.
10 APR 2006
| # | Name | Date |
|---|---|---|
| 1 | 451 mum-2005-abstract (complete).doc | 2018-08-09 |
| 1 | 451-MUM-2005_EXAMREPORT.pdf | 2018-08-09 |
| 2 | 451 mum-2005-abstract (complete).pdf | 2018-08-09 |
| 2 | 451-mum-2005-form 2(title page)-(provisional)-(8-4-2005).pdf | 2018-08-09 |
| 3 | 451-mum-2005-form 2(title page)-(complete)-(10-4-2006).pdf | 2018-08-09 |
| 4 | 451-mum-2005-form 2(complete)-(10-4-2006).pdf | 2018-08-09 |
| 4 | 451 mum-2005-claims (complete).pdf | 2018-08-09 |
| 5 | 451-MUM-2005-FORM 18(8-4-2009).pdf | 2018-08-09 |
| 5 | 451 mum-2005-correspondence-received-ver-10042006.pdf | 2018-08-09 |
| 6 | 451-mum-2005-form 1(8-4-2005).pdf | 2018-08-09 |
| 6 | 451 mum-2005-correspondence-received-ver-25052005.pdf | 2018-08-09 |
| 7 | 451-mum-2005-description(complete)-(10-4-2006).pdf | 2018-08-09 |
| 7 | 451 mum-2005-correspondence-received.pdf | 2018-08-09 |
| 8 | 451-MUM-2005-CORRESPONDENCE(IPO)-(6-12-2012).pdf | 2018-08-09 |
| 8 | 451 mum-2005-description (complete).pdf | 2018-08-09 |
| 9 | 451 mum-2005-description (provisional).pdf | 2018-08-09 |
| 9 | 451-MUM-2005-CORRESPONDENCE(8-4-2009).pdf | 2018-08-09 |
| 10 | 451 mum-2005-form-1.pdf | 2018-08-09 |
| 10 | 451-mum-2005-correspondence(8-4-2005).pdf | 2018-08-09 |
| 11 | 451 mum-2005-form-2 (complete).pdf | 2018-08-09 |
| 11 | 451-mum-2005-claims(complete)-(10-4-2006).pdf | 2018-08-09 |
| 12 | 451-mum-2005-abstract(10-4-2006).pdf | 2018-08-09 |
| 13 | 451 mum-2005-form-2 (provisional).pdf | 2018-08-09 |
| 13 | 451 mum-2005-form-5.pdf | 2018-08-09 |
| 14 | 451 mum-2005-form-26.pdf | 2018-08-09 |
| 14 | 451 mum-2005-form-3.pdf | 2018-08-09 |
| 15 | 451 mum-2005-form-26.pdf | 2018-08-09 |
| 15 | 451 mum-2005-form-3.pdf | 2018-08-09 |
| 16 | 451 mum-2005-form-2 (provisional).pdf | 2018-08-09 |
| 16 | 451 mum-2005-form-5.pdf | 2018-08-09 |
| 17 | 451-mum-2005-abstract(10-4-2006).pdf | 2018-08-09 |
| 18 | 451-mum-2005-claims(complete)-(10-4-2006).pdf | 2018-08-09 |
| 18 | 451 mum-2005-form-2 (complete).pdf | 2018-08-09 |
| 19 | 451 mum-2005-form-1.pdf | 2018-08-09 |
| 19 | 451-mum-2005-correspondence(8-4-2005).pdf | 2018-08-09 |
| 20 | 451 mum-2005-description (provisional).pdf | 2018-08-09 |
| 20 | 451-MUM-2005-CORRESPONDENCE(8-4-2009).pdf | 2018-08-09 |
| 21 | 451 mum-2005-description (complete).pdf | 2018-08-09 |
| 21 | 451-MUM-2005-CORRESPONDENCE(IPO)-(6-12-2012).pdf | 2018-08-09 |
| 22 | 451 mum-2005-correspondence-received.pdf | 2018-08-09 |
| 22 | 451-mum-2005-description(complete)-(10-4-2006).pdf | 2018-08-09 |
| 23 | 451 mum-2005-correspondence-received-ver-25052005.pdf | 2018-08-09 |
| 23 | 451-mum-2005-form 1(8-4-2005).pdf | 2018-08-09 |
| 24 | 451 mum-2005-correspondence-received-ver-10042006.pdf | 2018-08-09 |
| 24 | 451-MUM-2005-FORM 18(8-4-2009).pdf | 2018-08-09 |
| 25 | 451-mum-2005-form 2(complete)-(10-4-2006).pdf | 2018-08-09 |
| 25 | 451 mum-2005-claims (complete).pdf | 2018-08-09 |
| 26 | 451-mum-2005-form 2(title page)-(complete)-(10-4-2006).pdf | 2018-08-09 |
| 27 | 451-mum-2005-form 2(title page)-(provisional)-(8-4-2005).pdf | 2018-08-09 |
| 27 | 451 mum-2005-abstract (complete).pdf | 2018-08-09 |
| 28 | 451-MUM-2005_EXAMREPORT.pdf | 2018-08-09 |